Home>
US Stocks>
Universe Pharmaceuticals Inc

Universe Pharmaceuticals Inc share price today

(UPC)

Universe Pharmaceuticals Inc share price is $3.39 & ₹287.10 as on 7 Dec 2024, 2.30 'hrs' IST

$3.39

▲

2.34

(222.86%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Universe Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Universe Pharmaceuticals Inc from India. Also see the sentimental analysis on Indian investors investing in Universe Pharmaceuticals Inc. Get details on the Indian mutual funds that are investing in Universe Pharmaceuticals Inc. Get Analyst recommendations and forecasts along with all the Universe Pharmaceuticals Inc's financials.

Universe Pharmaceuticals Inc share price movements

$2.77
$4.71
$3.39
18.29%
Downside
Day's Volatility :41.19%
Upside
28.03%
$1.00
$64.80
$3.39
70.5%
Downside
52 Weeks Volatility :98.46%
Upside
94.77%

Universe Pharmaceuticals Inc Returns

Period	Universe Pharmaceuticals Inc	Index (Russel 2000)
3 Months	-97.6%	0.0%
6 Months	-97.13%	0.0%
1 Year	-95.14%	0.0%
3 Years	-99.37%	-21.5%

Universe Pharmaceuticals Inc Key Statistics

in dollars & INR

Previous Close	$1.05
Open	$3.02
Today's High	$4.71
Today's Low	$2.77
Market Capitalization	$2.8M
Today's Volume	$1.9M
52 Week High	$64.8
52 Week Low	$1.0
Revenue TTM	$26.7M
EBITDA	$-4.9M
Earnings Per Share (EPS)	$-67.47
Profit Margin	-69.41%
Quarterly Earnings Growth YOY	-0.82%
Return On Equity TTM	-50.22%

How to invest in Universe Pharmaceuticals Inc from India?

It is very easy for Indian residents to invest directly in Universe Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Universe Pharmaceuticals Inc stock in both rupees (INR) and dollars (USD). Search for Universe Pharmaceuticals Inc or UPC on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Universe Pharmaceuticals Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Universe Pharmaceuticals Inc shares which would translate to 0.250 fractional shares of Universe Pharmaceuticals Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Universe Pharmaceuticals Inc

144.44%

Period: Sep 8, 2024 to Dec 7, 2024. Change in 30 Days versus previous period

Investment in Universe Pharmaceuticals Inc from India has grown in the last 30 days as on Dec 8, 2024. 144.44% more purchase transactions for Universe Pharmaceuticals Inc in the last 30 days versus the previous period.

-87%

Period: Sep 8, 2024 to Dec 7, 2024. Change in 30 Days versus previous period

Search volume for Universe Pharmaceuticals Inc on INDmoney from India has reduced in the last 30 days as on Dec 8, 2024. -87% less investors are searching Universe Pharmaceuticals Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Universe Pharmaceuticals Inc

UBS Group AG
1.03%
TWO SIGMA SECURITIES, LLC
0.38%
Renaissance Technologies Corp
0.17%
Quadrature Capital LLP
0.11%
XTX Topco Ltd
0.06%
Millennium Management LLC
0.06%

Analyst Recommendation on Universe Pharmaceuticals Inc

Insights on Universe Pharmaceuticals Inc

Vs CTLT
In the last 1 year, Catalent, Inc. has given 65.9% return, outperforming this stock by 161.0%
Vs NBIX
In the last 3 years, Universe Pharmaceuticals Inc has experienced a drawdown of -99.3%, however Neurocrine Biosciences Inc. resisted the overall trend and outperformed by 49.6%

Universe Pharmaceuticals Inc Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$28.5M	-
Net Income	$7.6M	-
Net Profit Margin	26.66%	-

	FY19	Y/Y Change
Revenue	$33.2M	↑ 16.54%
Net Income	$7.6M	↓ 0.68%
Net Profit Margin	22.73%	↓ 3.93%

	FY20	Y/Y Change
Revenue	$30.7M	↓ 7.6%
Net Income	$7.6M	↑ 0.09%
Net Profit Margin	24.62%	↑ 1.89%

	FY21	Y/Y Change
Revenue	$48.0M	↑ 56.27%
Net Income	$11.3M	↑ 49.77%
Net Profit Margin	23.59%	↓ 1.03%

	FY22	Y/Y Change
Revenue	$40.1M	↓ 16.34%
Net Income	$-8.7M	↓ 177.18%
Net Profit Margin	-21.76%	↓ 45.35%

	FY23	Y/Y Change
Revenue	$32.3M	↓ 19.52%
Net Income	$-6.2M	↓ 29.46%
Net Profit Margin	-19.08%	↑ 2.68%

	Q4 FY22	Q/Q Change
Revenue	$15.9M	-
Net Income	$-10.5M	-
Net Profit Margin	-65.67%	-

	Q2 FY23	Q/Q Change
Revenue	$18.5M	-
Net Income	$-715.4K	-
Net Profit Margin	-3.87%	-

	Q4 FY23	Q/Q Change
Revenue	$13.8M	↓ 25.05%
Net Income	$-5.4M	↑ 661.45%
Net Profit Margin	-39.36%	↓ 35.49%

	Q2 FY24	Q/Q Change
Revenue	$12.9M	↓ 6.92%
Net Income	$-13.1M	↑ 140.5%
Net Profit Margin	-101.68%	↓ 62.32%

	FY18	Y/Y Change
Total Assets	$28.1M	-
Total Liabilities	$18.4M	-

	FY19	Y/Y Change
Total Assets	$17.8M	↓ 36.48%
Total Liabilities	$5.5M	↓ 70.36%

	FY20	Y/Y Change
Total Assets	$28.8M	↑ 61.49%
Total Liabilities	$8.0M	↑ 46.74%

	FY21	Y/Y Change
Total Assets	$70.1M	↑ 143.52%
Total Liabilities	$11.2M	↑ 40.11%

	FY22	Y/Y Change
Total Assets	$59.5M	↓ 15.12%
Total Liabilities	$13.1M	↑ 16.83%

	FY23	Y/Y Change
Total Assets	$53.3M	↓ 10.5%
Total Liabilities	$13.8M	↑ 5.01%

	Q4 FY22	Q/Q Change
Total Assets	$59.5M	↑ 0.0%
Total Liabilities	$13.1M	↑ 0.0%

	Q1 FY23	Q/Q Change
Total Assets	$70.4M	↑ 18.19%
Total Liabilities	$23.2M	↑ 77.45%

	Q2 FY23	Q/Q Change
Total Assets	$70.4M	↑ 0.0%
Total Liabilities	$23.2M	↑ 0.0%

	Q3 FY23	Q/Q Change
Total Assets	$53.3M	↓ 24.27%
Total Liabilities	$13.8M	↓ 40.82%

	Q4 FY23	Q/Q Change
Total Assets	$53.3M	↑ 0.0%
Total Liabilities	$13.8M	↑ 0.0%

	Q2 FY24	Q/Q Change
Total Assets	$49.4M	↓ 7.24%
Total Liabilities	$22.7M	↑ 64.94%

	FY18	Y/Y Change
Operating Cash Flow	$4.5M	-
Investing Cash Flow	$-145.1K	-
Financing Cash Flow	$-4.9M	-

	FY19	Y/Y Change
Operating Cash Flow	$13.2M	↑ 196.34%
Investing Cash Flow	$-86.0K	↓ 40.71%
Financing Cash Flow	$-16.0M	↑ 225.64%

	FY20	Y/Y Change
Operating Cash Flow	$6.1M	↓ 53.69%
Investing Cash Flow	$-51.8K	↓ 39.79%
Financing Cash Flow	$470.1K	↓ 102.94%

	FY21	Y/Y Change
Operating Cash Flow	$-2.1M	↓ 133.62%
Investing Cash Flow	$-27.1M	↑ 52141.32%
Financing Cash Flow	$26.6M	↑ 5554.07%

	FY22	Y/Y Change
Operating Cash Flow	$-1.3M	↓ 36.17%
Investing Cash Flow	$-3.9M	↓ 85.56%
Financing Cash Flow	$3.3M	↓ 87.52%

	Q3 FY22	Q/Q Change
Operating Cash Flow	$-3.7M	↓ 160.72%
Investing Cash Flow	$-1.9M	↑ 0.0%
Financing Cash Flow	$1.7M	↓ 8448.6%

	Q4 FY22	Q/Q Change
Operating Cash Flow	$-7.9M	↑ 112.66%
Investing Cash Flow	$-323.0	↓ 99.98%
Financing Cash Flow	$3.3M	↑ 100.0%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$2.4M	↓ 130.37%
Investing Cash Flow	$-323.0	↑ 0.0%
Financing Cash Flow	$1.0M	↓ 68.83%

Universe Pharmaceuticals Inc Technicals Summary

Sell

Neutral

Buy

Universe Pharmaceuticals Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Universe Pharmaceuticals Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Universe Pharmaceuticals Inc	-71.75%	-97.13%	-95.14%	-99.37%	-99.75%
Neurocrine Biosciences Inc.	1.97%	-6.15%	6.67%	54.89%	11.24%
Haleon Plc Spon Ads	1.35%	16.11%	18.37%	31.31%	31.31%
Zoetis Inc.	0.3%	-2.27%	-7.75%	-24.07%	42.34%
Viatris Inc.	-2.2%	22.65%	31.13%	2.38%	-21.11%
Catalent, Inc.	3.67%	10.55%	63.78%	-49.82%	17.01%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Universe Pharmaceuticals Inc	NA	NA	NA	0.0	-0.5	-0.06	NA	7.34
Neurocrine Biosciences Inc.	33.98	33.98	0.3	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	29.36	29.36	1.74	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	32.98	32.98	2.44	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.08	2.67	-0.04	0.02	0.04	16.58
Catalent, Inc.	211.02	NA	514.17	0.2	-0.11	0.0	NA	19.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Universe Pharmaceuticals Inc	NA	$2.8M	-99.75%	NA	-69.41%
Neurocrine Biosciences Inc.	Buy	$12.9B	11.24%	33.98	17.21%
Haleon Plc Spon Ads	Buy	$43.8B	31.31%	29.36	10.75%
Zoetis Inc.	Buy	$79.1B	42.34%	32.98	26.55%
Viatris Inc.	Hold	$15.1B	-21.11%	224.4	-5.87%
Catalent, Inc.	Hold	$11.2B	17.01%	211.02	-9.34%

About Universe Pharmaceuticals Inc

Organization	Universe Pharmaceuticals Inc
Employees	225
CEO	Mr. Gang Lai
Industry	Miscellaneous

Management People of Universe Pharmaceuticals Inc

Name	Title
Mr. Gang Lai	CEO & Chairman
Ms. Lin Yang	CFO & Director
Mr. Baochang Liu	Chief Operating Officer

Important FAQs about investing in Universe Pharmaceuticals Inc from India :

What is Universe Pharmaceuticals Inc share price today?

Universe Pharmaceuticals Inc (UPC) share price today is $3.39.

Can Indians buy Universe Pharmaceuticals Inc shares?

Yes, Indians can invest in the Universe Pharmaceuticals Inc (UPC) from India.

With INDmoney, you can buy Universe Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Universe Pharmaceuticals Inc at zero transaction cost.

How can I buy Universe Pharmaceuticals Inc shares from India?

It is very easy to buy Universe Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Universe Pharmaceuticals Inc be purchased?

Yes, you can buy fractional shares of Universe Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Universe Pharmaceuticals Inc stocks?

To start investing in Universe Pharmaceuticals Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Universe Pharmaceuticals Inc

Today’s highest price of Universe Pharmaceuticals Inc (UPC) is $4.71.

Today’s lowest price of Universe Pharmaceuticals Inc (UPC) is $2.77.

What is today's market capitalisation of Universe Pharmaceuticals Inc

Today's market capitalisation of Universe Pharmaceuticals Inc UPC is 2.8M

What is the 52 Week High and Low Range of Universe Pharmaceuticals Inc

52 Week High
$64.80
52 Week Low
$1.00

How much percentage Universe Pharmaceuticals Inc is down from its 52 Week High?

Universe Pharmaceuticals Inc (UPC) share price is $3.39. It is down by 99% from its 52 Week High price of $64.80.

How much percentage Universe Pharmaceuticals Inc is up from its 52 Week low?

Universe Pharmaceuticals Inc (UPC) share price is $3.39. It is up by 1% from its 52 Week Low price of $1.00.

What are the historical returns of Universe Pharmaceuticals Inc?

1 Month Returns
-71.75%
3 Months Returns
-97.13%
1 Year Returns
-95.14%
5 Years Returns
-99.75%

Who is the Chief Executive Officer (CEO) of Universe Pharmaceuticals Inc

Mr. Gang Lai is the current Chief Executive Officer (CEO) of Universe Pharmaceuticals Inc.

Discover More

Explore all